Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Japanese knotweed root (Polygonum cuspidatum) is a rich source of trans-resveratrol, emodin, polydatin, and anthraquinones that inhibit NF-κB and STAT3 signaling pathways, delivering potent anti-inflammatory, hepatoprotective, and cardiovascular benefits confirmed across multiple pharmacological reviews (PMID 36620922; PMID 34961091). In vitro research has further demonstrated that Japanese knotweed rhizome bark extract inhibits live SARS-CoV-2 viral replication (PMID 36134975), while its stilbene and anthraquinone compounds show broad bioactivity including antioxidant, antimicrobial, and neuroprotective effects (PMID 32365900).
Reported Benefits (Provisional)
Origin & History
Japanese Knotweed (Reynoutria japonica, formerly Fallopia japonica) is a resilient perennial plant native to East Asia, particularly Japan, China, and Korea, thriving along riverbanks and disturbed lands. Its rhizomes are a rich source of bioactive compounds, notably resveratrol, making it significant for functional nutrition.
Research Narrative (Provisional)
A comprehensive pharmacological review by Ke et al. (2023) in Pharmaceutical Biology catalogued over 100 bioactive compounds in Polygonum cuspidatum with documented anti-inflammatory, antiviral, hepatoprotective, and cardioprotective activities (PMID 36620922). Cucu et al. (2021) in Plants reviewed Fallopia japonica's polyphenol and stilbene profiles, confirming strong antioxidant and antimicrobial potential across in vitro models (PMID 34961091). Jug et al. (2022) in Bioengineering demonstrated that a Japanese knotweed rhizome bark extract significantly inhibited live SARS-CoV-2 replication in Vero E6 cell cultures, highlighting novel antiviral applications (PMID 36134975). Pogačnik et al. (2020) in Foods compared ethanol extracts of Japanese and Bohemian knotweed in vitro, finding that Japanese knotweed exhibited superior antioxidant, anti-acetylcholinesterase, and anti-inflammatory bioactivities (PMID 32365900).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Resveratrol: A potent polyphenol with significant antioxidant, anti-inflammatory, cardioprotective, and neuroprotective effects. - Emodin: An anthraquinone derivative contributing to its detoxifying properties. - Vitamin C: Supports immune function and collagen synthesis. - Minerals (Calcium, Magnesium, Iron): Essential for bone health, muscle function, and oxygen transport. - Dietary Fiber: Aids in digestive regularity and gut health.
Reported Mechanism (Provisional)
Trans-resveratrol, the primary stilbene in Japanese knotweed root, suppresses NF-κB signaling pathways, reducing downstream production of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β, and induces apoptosis in hepatoma cells via caspase 3/9 activation at concentrations of 2.5–40 μM (PMID 36620922). The anthraquinone emodin modulates AMPK/mTOR and Nrf2/HO-1 pathways, conferring hepatoprotective and antioxidant effects, while polydatin (resveratrol-3-O-β-D-glucoside) enhances bioavailability and activates SIRT1 to improve mitochondrial function (PMID 34961091). The compound 2-ethoxystypandrone blocks STAT3 phosphorylation with an IC₅₀ of 7.75 μM, disrupting oncogenic signaling, while citreorosein inhibits topoisomerase activity. A quinolinyl analog of resveratrol has also been shown to promote Parkin-mediated mitophagy via the PINK1/Parkin pathway, improving neuronal survival after ischemic stroke in preclinical models (PMID 39986697).
Clinical Narrative (Provisional)
Human clinical evidence remains limited, with only one double-blind, placebo-controlled trial conducted in 2013. This study involved 20 healthy male basketball players who received 200mg daily of Japanese knotweed extract standardized to 20% trans-resveratrol for 6 weeks, resulting in significant reduction of inflammatory markers compared to placebo. Most therapeutic claims are based on in vitro and animal studies, including resveratrol's demonstrated 41.7-60.9% tumor growth reduction at 10-30 mg/kg doses in animal models. Large-scale human trials are needed to confirm antitumor, antiviral, and hepatoprotective effects observed in laboratory settings.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.